SCHEMBL14430477

SCHEMBL14430477

Cc1ccc2c(c1)C(O)(C1CCN(C)CC1)C(C)(C)CC2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
SLC6A2 P23975 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP3A4 P08684 1/20 0.36
KMT2A Q03164 1/20 0.35
KDM1A O60341 2/20 0.34
SCN1A P35498 1/20 0.34
SCN2A Q99250 1/20 0.34
SCN3A Q9NY46 1/20 0.34
HRH4 Q9H3N8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
SLC6A3 Q01959 1/20 0.33
DRD2 P14416 1/20 0.32
DRD4 P21917 1/20 0.32
DRD3 P35462 1/20 0.32
PARP1 P09874 1/20 0.32
SRD5A1 P18405 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14430562 0.92 MAPK1 (0.45) MAPK1SMN1; SMN2SLC6A2GRIN1GRIN2A
SCHEMBL14430478 0.90 ALDH1A1 (0.43) MAPK1SMN1; SMN2SLC6A2GRIN1GRIN2A
SCHEMBL5199209 0.86 MAPK1 (0.42) MAPK1SMN1; SMN2SLC6A2GRIN1GRIN2A
SCHEMBL5200044 0.83 MAPK1 (0.64) MAPK1SMN1; SMN2ALDH1A1KDM1AL3MBTL1
SCHEMBL14430474 0.83 MAPK1 (0.45) MAPK1SMN1; SMN2SLC6A2GRIN1GRIN2A
SCHEMBL14430480 0.81 MAPK1 (0.39) MAPK1SMN1; SMN2
SCHEMBL14430599 0.80 MAPK1 (0.40) MAPK1SMN1; SMN2SLC6A2GRIN1GRIN2A
SCHEMBL5199517 0.80 MAPK1 (0.40) MAPK1SMN1; SMN2SLC6A2GRIN1GRIN2A
SCHEMBL14430432 0.79 MAPK1 (0.41) MAPK1SMN1; SMN2SLC6A2GRIN1GRIN2A
SCHEMBL14430606 0.78 MAPK1 (0.39) MAPK1SMN1; SMN2SLC6A2GRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197594-A1 Cyclic amine derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2007-08-23 US disclosed
US-20070197594-A1 Cyclic amine derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2007-08-23 US disclosed
EP-1795524-A1 CYCLIC AMINE DERIVATIVE OR SALT THEREOF Astellas Pharma Inc. (JP) 2007-06-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197594-A1 Cyclic amine derivative or salt thereof GRIN1, PARK7, GRIN3A MAPK1 664/4885SMN1; SMN2 46/4885SLC6A2 339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.